Is Mentari Therapeutics Stock a good buy in 2026, according to Wall Street analysts?
The consensus among 3 Wall Street analysts covering (NASDAQ: MTRI) stock is to Strong Buy MTRI stock.
Out of 3 analysts, 3 (100%) are recommending MTRI as a Strong Buy, 0 (0%) are recommending MTRI as a Buy, 0 (0%) are recommending MTRI as a Hold, 0 (0%) are recommending MTRI as a Sell, and 0 (0%) are recommending MTRI as a Strong Sell.
According to 3 Wall Street analysts that have issued a 1 year MTRI price target, the average MTRI price target is $34.00, with the highest MTRI stock price forecast at $42.00 and the lowest MTRI stock price forecast at $30.00.
On average, Wall Street analysts predict that Mentari Therapeutics's share price could reach $34.00 by Nov 10, 2027. The average Mentari Therapeutics stock price prediction forecasts a potential upside of 178.69% from the current MTRI share price of $12.20.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.